Spectrum Announces Expansion of the Poziotinib Clinical Program
Recent pre-clinical data supports development of poziotinib for osimertinib resistance, as well as atypical mutations. Three new cohorts are currently…
Pharmaceuticals, Biotechnology and Life Sciences
Recent pre-clinical data supports development of poziotinib for osimertinib resistance, as well as atypical mutations. Three new cohorts are currently…
Conference Call and Webcast Scheduled for 1:30 p.m. PDT SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, Inc. (Nasdaq: EPZM), a late-stage biopharmaceutical company developing novel epigenetic therapies, today announced the appointment of Paolo…
WALLINGFORD, England–(BUSINESS WIRE)–Research partners from pharma, academia, and SMEs have come together to form the Reward Task Optimisation Consortium (RTOC).…
Annual Sales Tracking to Exceed Previous Year Sales of $2 million SAN DIEGO–(BUSINESS WIRE)–Innovus Pharmaceuticals, Inc. (“Innovus Pharma” or the…
Milciclib was well tolerated and no drug related deaths were reported 28 out of 31 treated patients were evaluable, with…
Vedolizumab subcutaneous is currently under review for approval for ulcerative colitis with the European Medicines Agency (EMA) and U.S. Food…
Blood supplies are essential for saving lives, but China’s demand for blood exceeds supply. Detraxi, a biotechnology company, is working…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY), announces the closure of the…
WILLIAMSVILLE, N.Y.–(BUSINESS WIRE)–22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a world leader in tobacco…